Rolvedon to decrease infection following myelosuppressive anti-cancer drugs
Drug Name: Rolvedon Active Ingredient: eflapegrastim Indications: To decrease the incidence of infection in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with clinically significant incidence of febrile neutropenia…